Trial Identifier: | D5551L00018 |
Sponsor: | AstraZeneca |
NCTID:: | NCT02533453 |
Start Date: | January 2016 |
Primary Completion Date: | December 2016 |
Condition: | Diabetes: Type 2 |
For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.
Language | Description |
English translation | |
Korean translation |
Country | Location |
---|---|
South Korea | Busan, South Korea, 49241 |
South Korea | Daegu, South Korea, 700-712 |
South Korea | Daejeon, South Korea, 35015 |
South Korea | Gwangju, South Korea, 61469 |
South Korea | Incheon, South Korea, 405-760 |
South Korea | Seongnam-si, South Korea, 13620 |
South Korea | Seoul, South Korea, 06351 |
South Korea | Seoul, South Korea, 03722 |
South Korea | Seoul, South Korea, 06591 |
South Korea | Seoul, South Korea, 03080 |
South Korea | Seoul, South Korea, 05505 |
South Korea | Seoul, South Korea, 08308 |
South Korea | Seoul, South Korea, 130-872 |
South Korea | Suwon-si, South Korea, 16499 |
South Korea | Wonju-si, South Korea, 26426 |